These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26671309)

  • 1. A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping.
    Tembhare P; Badrinath Y; Ghogale S; Patkar N; Dhole N; Dalavi P; Kunder N; Kumar A; Gujral S; Subramanian PG
    Cytometry A; 2016 Mar; 89(3):281-91. PubMed ID: 26671309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method for DNA Ploidy Analysis Along with Immunophenotyping for Rare Populations in a Sample using FxCycle Violet.
    Tembhare P; Badrinath Y; Ghogale S; Subramanian PG
    Curr Protoc Cytom; 2017 Apr; 80():6.38.1-6.38.15. PubMed ID: 28369766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blast size-specific flowcytometric ploidy assessment using FxCycle
    Bommannan K; Arumugam JR; Koshy T; Radhakrishnan V; Sagar TG; Sundersingh S
    Int J Lab Hematol; 2021 Aug; 43(4):760-770. PubMed ID: 33345449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone.
    Gupta N; Parihar M; Banerjee S; Brahma S; Pawar R; Rath A; Shewale S; Singh M; Sasikumaran Nair Remani A; Krishnan S; Bhatacharyya A; Das A; Kumar J; Bhave S; Radhakrishnan V; Nair R; Chandy M; Mishra D; Arora N
    Cytometry B Clin Cytom; 2019 Sep; 96(5):359-367. PubMed ID: 30715800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
    Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
    Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DRAQ5: improved flow cytometric DNA content analysis and minimal residual disease detection in childhood malignancies.
    Swerts K; Van Roy N; Benoit Y; Laureys G; Philippé J
    Clin Chim Acta; 2007 Apr; 379(1-2):154-7. PubMed ID: 17229416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B-cell acute lymphoblastic leukemia using multicolor flow cytometry.
    Chaturvedi A; Shetty D; Ghogale SG; Deshpande N; Badrinath Y; Chatterjee G; Girase K; Sriram H; Khanka T; Mishra C; Dasgupta N; Gujarathi SA; Rajpal S; Patkar N; Amare-Kadam P; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2022 May; 102(3):199-208. PubMed ID: 35212133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow Cytometric DNA Ploidy Analysis in Haemato-Lymphoid Neoplasms: An Analysis of 132 Cases.
    Gupta N; Mittal A; Dadu T; Choudhary D; Handoo A
    Int J Hematol Oncol Stem Cell Res; 2022 Jan; 16(1):34-46. PubMed ID: 35975117
    [No Abstract]   [Full Text] [Related]  

  • 9. Flow cytometric DNA-quantification of three-color immunophenotyped cells for subpopulation specific determination of aneuploidy and proliferation.
    Oelschlaegel U; Freund D; Range U; Ehninger G; Nowak R
    J Immunol Methods; 2001 Jul; 253(1-2):145-52. PubMed ID: 11384676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection.
    Weir EG; Cowan K; LeBeau P; Borowitz MJ
    Leukemia; 1999 Apr; 13(4):558-67. PubMed ID: 10214862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy analysis as an adjunct for the detection of relapse in B-lineage acute lymphoblastic leukemia.
    Kenney B; Zieske A; Rinder H; Smith B
    Leuk Lymphoma; 2008 Jan; 49(1):42-8. PubMed ID: 18203010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow.
    Nowak R; Oelschlaegel U; Schuler U; Zengler H; Hofmann R; Ehninger G; Andreeff M
    Cytometry; 1997 Feb; 30(1):47-53. PubMed ID: 9056742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma.
    Almeida J; Orfao A; Ocqueteau M; Mateo G; Corral M; Caballero MD; Blade J; Moro MJ; Hernandez J; San Miguel JF
    Br J Haematol; 1999 Oct; 107(1):121-31. PubMed ID: 10520032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow immunophenotyping for the diagnosis of multiple myeloma: practical aspects].
    Kurtova AV; Sivachenko EB; Utkina LA; Slobodniuk KIu; Stepanova NV; Iakubovich MA; Moiseev SI; Zueva EE
    Klin Lab Diagn; 2008 Jan; (1):17-20. PubMed ID: 18314774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-10
    Tembhare PR; Subramanian Pg PG; Ghogale S; Chatterjee G; Patkar NV; Gupta A; Shukla R; Badrinath Y; Deshpande N; Narula G; Rodrigues P; Girase K; Dhaliwal D; Prasad M; Shetty D; Banavali S; Gujral S
    Cytometry B Clin Cytom; 2020 Jan; 98(1):57-67. PubMed ID: 31197916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hypodiploidy using multi-parameter flow cytometric analysis: a prognostic indicator in multiple myeloma.
    Morgan RJ; Gonchoroff NJ; Katzmann JA; Witzig TE; Kyle RA; Greipp PR
    Am J Hematol; 1989 Apr; 30(4):195-200. PubMed ID: 2929579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.